New York, Global Insight Services have recently published a report on Diabetic Nephropathy – Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Diabetic Nephropathy (DN) also called as diabetic kidney disease (DKD) is a long-term kidney damage or disease that can affect people with diabetes. Diabetic Nephropathy affects the ability of kidney to remove wastes and extra fluid from the body.
The most common cause of Diabetic Nephropathy is Type 1 and Type 2 Diabetes which increase the blood pressure. Any damage caused to blood vessels results in high blood pressure which will increase the pressure in the filtering system of the kidneys, which can cause severe damage lead to decreased kidney function and eventually kidney failure.
Symptoms include swollen ankles, feet, lower legs, or hands due to water retention, frequent urination, high blood pressure, darker urine due to traces of blood, shortness of breath, fatigue due to lack of oxygen in the blood, nausea, vomiting, poor appetite, metallic taste in the mouth, abnormal heart rhythm due to high potassium in blood.
Request sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS31085/
Doctors most often diagnose Diabetic Nephropathy by blood and urine tests, imaging tests, Renal function tests, Kidney biopsy.
The most common treatments for Diabetic Nephropathy are medications which will control the blood pressure, blood sugar, cholesterol level, and protein in the urine for the early stage and dialysis or Kidney transplant for advanced stage.
Report Highlights
Global Insight Service’s, Diabetic Nephropathy – Drug Pipeline Landscape, 2022 report provides an overview of the Diabetic Nephropathy pipeline drugs. This report covers detailed insights on Diabetic Nephropathy drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Diabetic Nephropathy pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Some of the key players involved in development of Diabetic Nephropathy therapeutics are :
• Aadi Biosciences
• Alebund Pharmaceuticals
• AptaBio Therapeutics Inc
• AstraZeneca
• Betagenon AB
• Bird Rock Bio Inc
• BLR Bio LLC
• Boehringer Ingelheim
• Caladrius Biosciences Inc
• Certa Therapeutics Pty Ltd
• Chinook Therapeutics
Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS31085/
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700